{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:41:43Z","timestamp":1787625703821,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10559-3","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:51:30Z","timestamp":1747738290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sepsis-related immune signature C3 in endometrial carcinoma: implications for prognosis, tumor progression through bioinformatics and experimental validation"],"prefix":"10.1007","volume":"52","author":[{"family":"Kulsoom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajahat","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleem","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanveen Kaur","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asia","family":"Masood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Omer","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valisher Sapayev Odilbek","family":"uglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukhayya Xusinovna","family":"Djumaniyazova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas Sameed","family":"Cholavaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubaraq Arisekola","family":"Abdulrahmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"10023","key":"10559_CR1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","volume":"387","author":"P Morice","year":"2016","unstructured":"Morice P et al (2016) Endometrial cancer. Lancet 387(10023):1094\u20131108","journal-title":"Lancet"},{"issue":"2","key":"10559_CR2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","volume":"21","author":"N Abu-Rustum","year":"2023","unstructured":"Abu-Rustum N et al (2023) Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 21(2):181\u2013209","journal-title":"J Natl Compr Canc Netw"},{"key":"10559_CR3","unstructured":"Luthringer, M. and J. Marziale, Endometrial cancer treatment (PDQ\u00ae): Treatment-health professional information [NCI]. Diabetes. 21: p. 22."},{"key":"10559_CR4","volume-title":"American cancer society: Cancer facts and figures","author":"V Cokkinides","year":"2005","unstructured":"Cokkinides V et al (2005) American cancer society: Cancer facts and figures. American Cancer Society, Atlanta"},{"issue":"5","key":"10559_CR5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/jcmm.17638","volume":"27","author":"X Wang","year":"2023","unstructured":"Wang X et al (2023) PHF6 promotes the progression of endometrial carcinoma by increasing cancer cells growth and decreasing T-cell infiltration. J Cell Mol Med 27(5):609\u2013621","journal-title":"J Cell Mol Med"},{"key":"10559_CR6","doi-asserted-by":"crossref","first-page":"107164","DOI":"10.1016\/j.compbiomed.2023.107164","volume":"163","author":"J Wu","year":"2023","unstructured":"Wu J et al (2023) Glycosyltransferase-related prognostic and diagnostic biomarkers of uterine corpus endometrial carcinoma. Comput Biol Med 163:107164","journal-title":"Comput Biol Med"},{"issue":"11","key":"10559_CR7","first-page":"881","volume":"137","author":"JC Williams","year":"2023","unstructured":"Williams JC, Ford ML, Coopersmith CM (2023) Cancer Sepsis Clin Sci 137(11):881\u2013893","journal-title":"Cancer Sepsis Clin Sci"},{"issue":"3","key":"10559_CR8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jcrc.2011.06.014","volume":"27","author":"MM Rosolem","year":"2012","unstructured":"Rosolem MM et al (2012) Critically ill patients with cancer and sepsis: clinical course and prognostic factors. J Crit Care 27(3):301\u2013307","journal-title":"J Crit Care"},{"issue":"10","key":"10559_CR9","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.4049\/jimmunol.2000865","volume":"206","author":"C-w Chen","year":"2021","unstructured":"Chen C-w et al (2021) Tumor-specific T cells exacerbate mortality and immune dysregulation during sepsis. J Immunol 206(10):2412\u20132419","journal-title":"J Immunol"},{"issue":"6","key":"10559_CR10","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1378\/chest.129.6.1432","volume":"129","author":"PA Danai","year":"2006","unstructured":"Danai PA et al (2006) The epidemiology of sepsis in patients with malignancy. Chest 129(6):1432\u20131440","journal-title":"Chest"},{"issue":"9","key":"10559_CR11","doi-asserted-by":"crossref","first-page":"e30547","DOI":"10.1002\/pbc.30547","volume":"70","author":"S Keerthivasagam","year":"2023","unstructured":"Keerthivasagam S et al (2023) Does granulocyte transfusion help pediatric cancer patients with sepsis? Pediatr Blood Cancer 70(9):e30547","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10559_CR12","first-page":"10099","volume":"30","author":"L Nazer","year":"2022","unstructured":"Nazer L et al (2022) All-cause mortality in cancer patients treated for sepsis in intensive care units: a systematic review and meta-analysis. Support Care Cancer 30(12):10099\u201310109","journal-title":"Support Care Cancer"},{"issue":"12","key":"10559_CR13","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1177\/0300060518789040","volume":"46","author":"Y Wang","year":"2018","unstructured":"Wang Y, Zhou, Wu K-s (2018) High 28-day mortality in critically ill patients with sepsis and concomitant active cancer. J Int Med Res 46(12):5030\u20135039","journal-title":"J Int Med Res"},{"key":"10559_CR14","doi-asserted-by":"crossref","unstructured":"Agostinis C et al (2021) The inflammatory Feed-Forward loop triggered by the complement component C3 as a potential target in endometriosis. Front Immunol, Volume 12\u20132021","DOI":"10.3389\/fimmu.2021.693118"},{"issue":"1","key":"10559_CR15","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1186\/s12885-024-12522-0","volume":"24","author":"K Akkour","year":"2024","unstructured":"Akkour K et al (2024) Plasma-based proteomic profiling identifies the distinct regulation of proteins in hyperplasia and endometrial cancer. BMC Cancer 24(1):752","journal-title":"BMC Cancer"},{"issue":"1","key":"10559_CR16","first-page":"101","volume":"11","author":"M GOJOBORI","year":"1981","unstructured":"GOJOBORI M et al (1981) Serum complement levels in uterine cervical Cancer patients and their relationship to Cell-Mediated immunity. Jpn J Clin Oncol 11(1):101\u2013108","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"10559_CR17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.thromres.2011.11.013","volume":"129","author":"P Della Valle","year":"2012","unstructured":"Della Valle P, Pavani G, D\u2019Angelo A (2012) The protein C pathway and sepsis. Thromb Res 129(3):296\u2013300","journal-title":"Thromb Res"},{"issue":"1","key":"10559_CR18","first-page":"25","volume":"2","author":"M Yusuf","year":"2013","unstructured":"Yusuf M et al (2013) Assessment of protein C, protein S, and prothrombin levels in Gastrointestinal carcinoma with and without metastasis. Clin Cancer Invest J 2(1):25","journal-title":"Clin Cancer Invest J"},{"issue":"7","key":"10559_CR19","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1097\/00003246-200107001-00020","volume":"29","author":"BW Grinnell","year":"2001","unstructured":"Grinnell BW, Joyce D (2001) Recombinant human activated protein C: a system modulator of vascular function for treatment of severe sepsis. Crit Care Med 29(7):S53\u2013S60","journal-title":"Crit Care Med"},{"issue":"1","key":"10559_CR20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13054-022-03889-2","volume":"26","author":"V Catenacci","year":"2022","unstructured":"Catenacci V et al (2022) The prognostic utility of protein C as a biomarker for adult sepsis: a systematic review and meta-analysis. Crit Care 26(1):21","journal-title":"Crit Care"},{"issue":"11","key":"10559_CR21","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.ekir.2023.08.033","volume":"8","author":"BP Dixon","year":"2023","unstructured":"Dixon BP et al (2023) Clinical safety and efficacy of Pegcetacoplan in a phase 2 study of patients with C3 glomerulopathy and other Complement-Mediated glomerular diseases. Kidney Int Rep 8(11):2284\u20132293","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10559_CR22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s43018-021-00173-0","volume":"2","author":"E Magrini","year":"2021","unstructured":"Magrini E et al (2021) Complement activation promoted by the lectin pathway mediates C3aR-dependent sarcoma progression and immunosuppression. Nat Cancer 2(2):218\u2013232","journal-title":"Nat Cancer"},{"key":"10559_CR23","doi-asserted-by":"crossref","unstructured":"Nunez-Cruz S et al (2009) Genetic approach to study complement role in ovarian Cancer (88.24). J Immunol, 182(1_Supplement): p. 88.24\u201388.24.","DOI":"10.4049\/jimmunol.182.Supp.88.24"},{"key":"10559_CR24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12026-012-8381-8","volume":"56","author":"SI Vlaicu","year":"2013","unstructured":"Vlaicu SI et al (2013) Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer. Immunol Res 56:109\u2013121","journal-title":"Immunol Res"},{"key":"10559_CR25","doi-asserted-by":"crossref","first-page":"101642","DOI":"10.1016\/j.smim.2022.101642","volume":"60","author":"E Magrini","year":"2022","unstructured":"Magrini E et al (2022) Complement activation in cancer: effects on tumor-associated myeloid cells and immunosuppression. Semin Immunol 60:101642","journal-title":"Semin Immunol"},{"issue":"1","key":"10559_CR26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12929-015-0151-1","volume":"22","author":"MA Khan","year":"2015","unstructured":"Khan MA, Assiri AM, Broering DC (2015) Complement and macrophage crosstalk during process of angiogenesis in tumor progression. J Biomed Sci 22(1):58","journal-title":"J Biomed Sci"},{"issue":"7","key":"10559_CR27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1158\/2326-6066.CIR-18-0891","volume":"7","author":"LT Roumenina","year":"2019","unstructured":"Roumenina LT et al (2019) Tumor cells hijack Macrophage-Produced complement C1q to promote tumor growth. Cancer Immunol Res 7(7):1091\u20131105","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"10559_CR28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1245\/s10434-015-4778-7","volume":"23","author":"S Downs-Canner","year":"2016","unstructured":"Downs-Canner S et al (2016) Complement Inhibition: A novel form of immunotherapy for Colon cancer. Ann Surg Oncol 23(2):655\u2013662","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10559_CR29","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1593\/neo.04250","volume":"6","author":"KE de Visser","year":"2004","unstructured":"de Visser KE, Korets LV, Coussens LM (2004) Early neoplastic progression is complement independent. Neoplasia 6(6):768\u2013776","journal-title":"Neoplasia"},{"key":"10559_CR30","doi-asserted-by":"crossref","first-page":"113059","DOI":"10.1016\/j.expneurol.2019.113059","volume":"322","author":"F Bu","year":"2019","unstructured":"Bu F et al (2019) Activation of endothelial ras-related C3 botulinum toxin substrate 1 (Rac1) improves post-stroke recovery and angiogenesis via activating Pak1 in mice. Exp Neurol 322:113059","journal-title":"Exp Neurol"},{"key":"10559_CR31","doi-asserted-by":"crossref","first-page":"709210","DOI":"10.3389\/fonc.2021.709210","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu Y et al (2021) Single-Cell transcriptomics reveals the complexity of the tumor microenvironment of Treatment-Naive osteosarcoma. Front Oncol 11:709210","journal-title":"Front Oncol"},{"key":"10559_CR32","doi-asserted-by":"crossref","unstructured":"G\u00f6tz P et al (2021) C3 deficiency leads to increased angiogenesis and elevated Pro-Angiogenic leukocyte recruitment in ischemic muscle tissue. Int J Mol Sci, 22(11)","DOI":"10.3390\/ijms22115800"},{"key":"10559_CR33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.molimm.2021.11.010","volume":"141","author":"S Shahgaldi","year":"2022","unstructured":"Shahgaldi S, Rezaei F, Kahmini, Moazzeni SM (2022) Mesenchymal stem cell therapy attenuates complement C3 deposition and improves the delicate equilibrium between angiogenic and anti-angiogenic factors in abortion-prone mice. Mol Immunol 141:246\u2013256","journal-title":"Mol Immunol"},{"key":"10559_CR34","doi-asserted-by":"crossref","unstructured":"Lawal B et al (2021) Pan-Cancer analysis of immune complement signature C3\/C5\/C3AR1\/C5AR1 in association with tumor immune evasion and therapy resistance. Cancers (Basel), 13(16)","DOI":"10.3390\/cancers13164124"},{"issue":"4","key":"10559_CR35","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3350\/cmh.2024.0229","volume":"30","author":"A Magdy","year":"2024","unstructured":"Magdy A et al (2024) DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol 30(4):824\u2013844","journal-title":"Clin Mol Hepatol"},{"key":"10559_CR36","doi-asserted-by":"crossref","first-page":"685065","DOI":"10.3389\/fonc.2021.685065","volume":"11","author":"J Shen","year":"2021","unstructured":"Shen J et al (2021) Comprehensive landscape of ovarian Cancer immune microenvironment based on integrated Multi-Omics analysis. Front Oncol 11:685065","journal-title":"Front Oncol"},{"key":"10559_CR37","first-page":"p5426887","volume":"2022","author":"Z Hu","year":"2022","unstructured":"Hu Z et al (2022) Hyper-Methylated hub genes of T-Cell receptor signaling predict a poor clinical outcome in lung adenocarcinoma. J Oncol 2022:p5426887","journal-title":"J Oncol"},{"key":"10559_CR38","doi-asserted-by":"crossref","first-page":"1177847","DOI":"10.3389\/fimmu.2023.1177847","volume":"14","author":"J Shu","year":"2023","unstructured":"Shu J, Jiang J, Zhao G (2023) Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis. Front Immunol 14:1177847","journal-title":"Front Immunol"},{"issue":"18","key":"10559_CR39","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.7150\/thno.77281","volume":"12","author":"Y Liang","year":"2022","unstructured":"Liang Y et al (2022) Single-cell atlases link macrophages and CD8(+) T-cell subpopulations to disease progression and immunotherapy response in urothelial carcinoma. Theranostics 12(18):7745\u20137759","journal-title":"Theranostics"},{"issue":"12","key":"10559_CR40","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","volume":"14","author":"WH Fridman","year":"2017","unstructured":"Fridman WH et al (2017) The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol 14(12):717\u2013734","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10559_CR41","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ccell.2021.05.016","volume":"39","author":"MO Li","year":"2021","unstructured":"Li MO et al (2021) Innate immune cells in the tumor microenvironment. Cancer Cell 39(6):725\u2013729","journal-title":"Cancer Cell"},{"issue":"9","key":"10559_CR42","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.21037\/tcr-24-704","volume":"13","author":"R Zhou","year":"2024","unstructured":"Zhou R et al (2024) BUB1 as a novel marker for predicting the immunotherapy efficacy and prognosis of breast cancer. Transl Cancer Res 13(9):4534\u20134554","journal-title":"Transl Cancer Res"},{"issue":"5","key":"10559_CR43","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M et al (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24(5):541\u2013550","journal-title":"Nat Med"},{"issue":"2","key":"10559_CR44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12032-022-01647-6","volume":"39","author":"S Wu","year":"2022","unstructured":"Wu S et al (2022) Bioinformatics analysis of C3 in brain low-grade gliomas as potential therapeutic target and promoting immune cell infiltration. Med Oncol 39(2):27","journal-title":"Med Oncol"},{"key":"10559_CR45","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s40064-016-1920-3","volume":"5","author":"AJ Cozzo","year":"2016","unstructured":"Cozzo AJ et al (2016) cMET inhibitor Crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer. Springerplus 5:348","journal-title":"Springerplus"},{"issue":"1","key":"10559_CR46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13046-019-1514-3","volume":"39","author":"K Yuan","year":"2020","unstructured":"Yuan K et al (2020) Complement C3 overexpression activates JAK2\/STAT3 pathway and correlates with gastric cancer progression. J Experimental Clin Cancer Res 39(1):9","journal-title":"J Experimental Clin Cancer Res"},{"key":"10559_CR47","doi-asserted-by":"crossref","unstructured":"Wollin L et al (2019) Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases. Eur Respir J, 54(3)","DOI":"10.1183\/13993003.00161-2019"},{"key":"10559_CR48","doi-asserted-by":"crossref","first-page":"1072612","DOI":"10.3389\/fimmu.2022.1072612","volume":"13","author":"L Pan","year":"2022","unstructured":"Pan L et al (2022) Nintedanib in an elderly non-small-cell lung cancer patient with severe steroid-refractory checkpoint inhibitor-related pneumonitis: A case report and literature review. Front Immunol 13:1072612","journal-title":"Front Immunol"}],"updated-by":[{"DOI":"10.1007\/s11033-025-10693-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000}}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10559-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10559-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10559-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T16:32:01Z","timestamp":1766853121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10559-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10559"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10559-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: the author \u201cFu Wang\u201d name has been removed from the author group.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11033-025-10693-y","URL":"https:\/\/doi.org\/10.1007\/s11033-025-10693-y","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article contains no studies involving human participants or animals performed by authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"471"}}